2019 WSES guidelines for the management of severe acute pancreatitis

Ari Leppäniemi,Matti Tolonen,Antonio Tarasconi,Helmut Segovia-Lohse,Emiliano Gamberini,Andrew W. Kirkpatrick,Chad G. Ball,Neil Parry,Massimo Sartelli,Daan Wolbrink,Harry van Goor,Gianluca Baiocchi,Luca Ansaloni,Walter Biffl,Federico Coccolini,Salomone Di Saverio,Yoram Kluger,Ernest Moore,Fausto Catena
DOI: https://doi.org/10.1186/s13017-019-0247-0
2019-06-13
World Journal of Emergency Surgery
Abstract:Although most patients with acute pancreatitis have the mild form of the disease, about 20–30% develops a severe form, often associated with single or multiple organ dysfunction requiring intensive care. Identifying the severe form early is one of the major challenges in managing severe acute pancreatitis. Infection of the pancreatic and peripancreatic necrosis occurs in about 20–40% of patients with severe acute pancreatitis, and is associated with worsening organ dysfunctions. While most patients with sterile necrosis can be managed nonoperatively, patients with infected necrosis usually require an intervention that can be percutaneous, endoscopic, or open surgical. These guidelines present evidence-based international consensus statements on the management of severe acute pancreatitis from collaboration of a panel of experts meeting during the World Congress of Emergency Surgery in June 27–30, 2018 in Bertinoro, Italy. The main topics of these guidelines fall under the following topics: Diagnosis, Antibiotic treatment, Management in the Intensive Care Unit, Surgical and operative management, and Open abdomen.
surgery,emergency medicine
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is related to the management of severe acute pancreatitis (SAP). Specifically, the objectives of the paper include: 1. **Early identification of the severe form**: The paper emphasizes the importance of early identification of SAP, because approximately 20% - 30% of acute pancreatitis patients will develop into the severe form, which is usually associated with single or multiple organ dysfunctions and requires intensive care. 2. **Management of infected necrosis**: Approximately 20% - 40% of SAP patients will have infected necrosis of the pancreas and surrounding tissues, which will lead to further deterioration of organ functions. The paper discusses how to manage and intervene in these infected necroses, including the choice between non - surgical and surgical treatments. 3. **International consensus guidelines**: The paper presents evidence - based international consensus statements, aiming to provide guidance for the management of SAP. These guidelines were developed collaboratively by an expert panel during the International Congress of Emergency Surgery held in Bertinoro, Italy, from June 27 to 30, 2018. 4. **Diagnostic criteria and imaging examinations**: The paper discusses in detail the diagnostic criteria for SAP, including the use of laboratory parameters and imaging examinations (such as ultrasound, CT, MRI, etc.) to determine the severity of the disease and complications. 5. **Antibiotic treatment**: The paper explores the role of antibiotics in the management of SAP, especially in the prevention and treatment of infected necrosis. 6. **Intensive care unit management**: The paper discusses the management strategies for SAP patients in the intensive care unit (ICU), including fluid resuscitation, pain management, and nutritional support. 7. **Surgical and operative management**: The paper covers the surgical and operative management of SAP, including different methods such as percutaneous, endoscopic, and open surgeries and their indications. 8. **Open - abdomen management**: The paper also discusses the application of the open - abdomen technique in the management of SAP in certain situations. In conclusion, by integrating the opinions of international experts and the latest research evidence, this paper aims to provide comprehensive and systematic guidance for the clinical management of SAP, in order to improve the survival rate of patients and reduce complications.